Contents | ||
Introduction
|
||
Purpose
|
2
|
|
Abbreviations
|
3
|
|
Key metrics
|
4
|
|
Regulatory framework for disclosures
|
6
|
|
Pillar 3 Disclosures 2015
|
7
|
|
Linkage to the Annual Report and Accounts 2015 | 7 | |
Capital and risk
|
||
Capital management
|
16
|
|
Overview of regulatory capital framework
|
16
|
|
Composition of regulatory capital
|
19
|
|
Pillar 1 requirements and RWA flow
|
21
|
|
Pillar 2 and ICAAP
|
25
|
|
Leverage ratio
|
27
|
|
Regulatory developments
|
28
|
|
Risk management
|
31
|
|
Credit risk
|
||
Overview and responsibilities
|
34
|
|
Credit risk management
|
34
|
|
Credit risk models governance
|
35
|
|
Application of the IRB approach
|
46
|
|
Model performance
|
66
|
|
Risk mitigation
|
74
|
|
Application of the standardised approach
|
76
|
|
Counterparty credit risk
|
78
|
|
Securitisation
|
85
|
|
Market risk
|
||
Overview and objectives
|
90
|
|
Market risk governance
|
90
|
|
Market risk measures
|
92
|
|
Market risk capital models
|
93
|
|
Trading portfolios
|
95
|
|
Non-trading portfolios
|
96
|
|
Prudent valuation adjustment
|
96
|
|
Structural foreign exchange exposures
|
96
|
|
Non-trading interest rate risk
|
97
|
|
Operational risk
|
||
Overview and objectives
|
99
|
|
Organisation and responsibilities
|
99
|
|
Measurement and monitoring
|
100
|
|
Other risks
|
||
Pension risk
|
101
|
|
Non-trading book exposures in equities
|
101
|
|
Risk management of insurance operations
|
101
|
|
Liquidity and funding risk
|
102
|
|
Reputational risk
|
103
|
|
Sustainability risk
|
103
|
|
Business risk
|
103
|
|
Dilution risk
|
103
|
|
Remuneration
|
103
|
|
Appendices
|
||
I
|
Simplified organisation chart for regulatory purposes
|
104
|
II
|
Asset encumbrance
|
105
|
III
|
Transitional own funds disclosure
|
106
|
IV
|
PD, LGD, RWA and exposure by country
|
109
|
V
|
Summary of disclosures withheld due to their immateriality, confidentiality or proprietary nature
|
116
|
VI
|
Glossary
|
117
|
VII
|
Cautionary statement regarding forward-looking statements
|
125
|
VIII
|
Contacts
|
126
|
Tables
|
|||
1
|
Pillar 1 overview
|
5
|
|
2
|
RWAs - by global business and region
|
5
|
|
3
|
RWAs - by risk type and region
|
6
|
|
4
|
Reconciliation of balance sheets - financial accounting to regulatory scope of consolidation
|
8
|
|
5
|
Principal entities with a different regulatory and accounting scope of consolidation
|
12
|
|
6
|
a) Mapping of financial statement categories with regulatory risk categories
|
14
|
|
6
|
b) Main sources of differences between regulatory exposure values and carrying values in financial statements
|
15
|
|
7
|
Composition of regulatory capital
|
20
|
|
8
|
Reconciliation of regulatory capital from transitional basis to an estimated CRD IV end point basis
|
21
|
|
9
|
Total RWAs by risk type
|
21
|
|
10
|
Credit risk - RWAs by region and approach
|
22
|
|
11
|
Credit risk - RWAs by global business and approach
|
22
|
|
12
|
RWA movement by region by key driver - credit risk IRB only
|
23
|
|
13
|
RWA movement by global business by key driver - credit risk - IRB only
|
23
|
|
14
|
Counterparty credit risk RWAs
|
24
|
|
15
|
RWA movement by key driver - CCR - advanced approach
|
24
|
|
16
|
Market risk RWAs
|
25
|
|
17
|
RWA movement by key driver - market risk - model based
|
25
|
|
18
|
Summary reconciliation of accounting assets and leverage ratio exposures
|
27
|
|
19
|
Leverage ratio common disclosure
|
27
|
|
20
|
Leverage ratio - split of on-balance sheet exposures
|
28
|
|
21
|
Credit risk - summary
|
36
|
|
22
|
Credit risk exposure - by region
|
37
|
|
23
|
Credit risk - RWAs by region
|
38
|
|
24
|
Credit risk - RWA density by region
|
40
|
|
25
|
Credit risk exposure - by industry sector
|
42
|
|
26
|
Credit risk exposure - by residual maturity
|
44
|
|
27
|
Wholesale IRB credit risk models
|
48
|
|
28
|
Wholesale IRB portfolio analysis
|
49
|
|
29
|
Wholesale IRB exposures under the slotting approach
|
49
|
|
30
|
Wholesale IRB exposure - by obligor grade
|
50
|
|
31
|
Material retail IRB risk rating systems
|
57
|
32
|
Retail IRB portfolio analysis
|
59
|
33
|
Retail IRB exposures secured by mortgages on immovable property (non-SME)
|
60
|
34
|
Retail IRB exposure - by internal PD band
|
61
|
35
|
Retail IRB exposure - by region
|
64
|
36
|
IRB models - estimated and actual values (wholesale)
|
67
|
37
|
IRB models - corporate PD models - performance by CRR
|
67
|
38
|
IRB models - estimated and actual values (retail)
|
70
|
39
|
Past due but not impaired exposures, impaired exposures and impairment allowances and other credit risk provisions by counterparty and region
|
71
|
40
|
Movement in specific CRAs by counterparty and region
|
71
|
41
|
IRB EL and CRAs - by exposure class
|
73
|
42
|
IRB EL and CRAs - by region
|
73
|
43
|
IRB exposure - credit risk mitigation
|
76
|
44
|
Standardised exposure - credit risk mitigation
|
77
|
45
|
Standardised exposure - by credit quality step
|
77
|
46
|
CCR exposure - credit derivative transactions
|
79
|
47
|
CCR - net derivative credit exposure
|
79
|
48
|
Comparison of derivative accounting balances and CCR exposure
|
80
|
49
|
CCR exposure - by exposure class, product and method
|
81
|
50
|
CCR exposure - by exposure class, product and region
|
82
|
51
|
CCR - RWAs by exposure class, product and region
|
83
|
52
|
CCR - RWA density by exposure class, product and region
|
84
|
53
|
Securitisation - by approach
|
87
|
54
|
Securitisation - movement in the year
|
87
|
55
|
Securitisation - by trading and non-trading book
|
88
|
56
|
Securitisation - asset values and impairments
|
88
|
57
|
Securitisation - by risk weighting
|
89
|
58
|
Market risk RWAs and capital required
|
91
|
59
|
Market risk models
|
94
|
60
|
VaR used for regulatory purposes (one-day equivalent)
|
94
|
61
|
Stressed VaR (one-day equivalent)
|
94
|
62
|
Incremental risk charge
|
95
|
63
|
Operational risk RWAs
|
99
|
64
|
Non-trading book equity investments
|
101
|
65
|
Asset encumbrance
|
105
|
66
|
Transitional own funds disclosure
|
106
|
67
|
PD, LGD, RWA and exposure by country
|
109
|
|
· to provide useful information on the capital and risk profile of the HSBC Group, and
|
|
· to meet the regulatory disclosure requirements under the Capital Requirements Regulation (EU) No 575/2013, Part 8 - Disclosure by institutions and the rules of the PRA set out in the Public Disclosure section of the PRA Rulebook and as the PRA has otherwise directed.
|
Abbreviation
|
Brief description
|
A
|
|
ABCP
|
Asset-backed commercial paper
|
ABS1
|
Asset-backed Security
|
AFS1
|
Available-for-sale
|
ALCM
|
Asset, Liability and Capital Management
|
ALCO
|
Asset and Liability Management Committee
|
AT1 capital
|
Additional Tier 1 capital
|
B
|
|
Basel Committee
|
Basel Committee on Banking Supervision
|
BoCom
|
Bank of Communications Co., Limited
|
BSM
|
Balance Sheet Management
|
C
|
|
CCB1
|
Capital conservation buffer
|
CCF1
|
Credit conversion factor
|
CCP
|
Central counterparty
|
CCR1
|
Counterparty credit risk
|
CCyB1
|
Countercyclical capital buffer
|
CDS1
|
Credit default swap
|
CET11
|
Common equity tier 1
|
CIU
|
Collective investment undertakings
|
CML1
|
Consumer and Mortgage Lending (US)
|
CRA1
|
Credit risk adjustment
|
CRD1
|
Capital Requirements Directive
|
CRE1
|
Commercial real estate
|
CRR1
|
Customer risk rating
|
CSA1
|
Credit Support Annex
|
CVA
|
Credit valuation adjustment
|
E
|
|
EAD1
|
Exposure at default
|
EBA
|
European Banking Authority
|
ECAI1
|
External Credit Assessment Institutions
|
EEA
|
European Economic Area
|
EL1
|
Expected loss
|
EU
|
European Union
|
EVE1
|
Economic value of equity
|
F
|
|
Fitch
|
Fitch Group
|
FPC1
|
Financial Policy Committee (UK)
|
FSB
|
Financial Stability Board
|
G
|
|
GAC
|
Group Audit Committee
|
GB&M
|
Global Banking and Markets, a global business
|
GMB
|
Group Management Board
|
GPB
|
Global Private Banking, a global business
|
GRC
|
Group Risk Committee
|
Group
|
HSBC Holdings together with its subsidiary undertakings
|
G-SIB1
|
Global systemically important bank
|
G-SII
|
Global systemically important institution
|
H
|
|
HKMA
|
Hong Kong Monetary Authority
|
Hong Kong
|
The Hong Kong Special Administrative Region of the People's Republic of China
|
HSBC
|
HSBC Holdings together with its subsidiary undertakings
|
I
|
|
IAA1
|
Internal Assessment Approach
|
Abbreviation
|
Brief description
|
ICAAP1
|
Internal Capital Adequacy Assessment Process
|
ICG
|
Individual capital guidance
|
IFRSs
|
International Financial Reporting Standards
|
IMM1
|
Internal Model Method
|
IRB1
|
Internal ratings-based approach
|
IRC1
|
Incremental risk charge
|
ITS
|
Implementing Technical Standards
|
L
|
|
LGD1
|
Loss given default
|
Libor
|
London Interbank Offered Rate
|
M
|
|
MDB1
|
Multilateral Development Bank
|
MENA
|
Middle East and North Africa
|
MOC
|
Model Oversight Committee
|
Moody's
|
Moody's Investor Service
|
MREL
|
Minimum requirements for own funds and eligible liabilities
|
N
|
|
NCOA
|
Non-credit obligation asset
|
O
|
|
ORMF
|
Operational risk management framework
|
OTC1
|
Over-the-counter
|
P
|
|
PD1
|
Probability of default
|
PFE1
|
Potential future exposure
|
PIT1
|
Point-in-time
|
PRA1
|
Prudential Regulation Authority (UK)
|
PVA1
|
Prudent valuation adjustment
|
R
|
|
RBM1
|
Ratings Based Method
|
Retail IRB1
|
Retail Internal Ratings Based approach
|
RMM
|
Risk Management Meeting of the GMB
|
RNIV
|
Risks not in VaR
|
RTS
|
Regulatory Technical Standards
|
RWA1
|
Risk-weighted asset
|
S
|
|
S&P
|
Standard and Poor's rating agency
|
SFM1
|
Supervisory Formula Method
|
SFT1
|
Securities Financing Transactions
|
SIC
|
Securities Investment Conduit
|
SME
|
Small and medium-sized enterprise
|
SPE1
|
Special Purpose Entity
|
SRB1
|
Systemic Risk Buffer
|
STD1
|
Standardised approach
|
T
|
|
TLAC1
|
Total Loss Absorbing Capacity
|
TTC1
|
Through-the-cycle
|
T2 capital
|
Tier 2 capital
|
U
|
|
UK
|
United Kingdom
|
$
|
United States dollar
|
US
|
United States of America
|
V
|
|
VaR1
|
Value at risk
|
|
1 Full definition included in Glossary in Appendix VI.
|
We are more than 250,000 employees working around the world to provide over 47 million customers with a broad range of banking products and services to meet their financial needs.
|
Our values
Our values define who we are as an organisation and make us distinctive.
Open
We are open to different ideas and cultures, and value diverse perspectives.
Connected
We are connected to our customers, communities, regulators and each other, caring about individuals and their progress.
Dependable
We are dependable, standing firm for what is right and delivering on commitments.
150-year heritage
These values reflect the best aspects of our 150-year heritage. They are critical to fulfilling our purpose to help businesses to thrive, economies to prosper and people to realise their ambitions.
|
Our role in society
How we do business is as important as what we do.
We seek to build trusting and lasting relationships with our many stakeholders to generate value in society and deliver long-term shareholder returns.
Further details on how we do business can be found on page 34 of the Annual Report and Accounts 2015
|
CRD IV
|
||||
Common equity tier 1 ratio1
(end point)
11.9%
2014: 11.1%
|
Tier 1 ratio
(transitional)
13.9%
2014: 12.5%
|
Total capital ratio
(transitional)
17.2%
2014: 15.6%
|
||
Common equity tier 1 capital1
(end point)
$130.9bn
- down 4%
2014: $136.0bn
|
Tier 1 capital
(transitional)
$153.3bn
- unchanged
2014: $152.7bn
|
Total regulatory capital
(transitional)
$189.8bn
- unchanged
2014: $190.7bn
|
||
Total RWAs
$1,103bn
- down 10%
2014: $1,220bn
|
Credit risk2 EAD
$2,147bn
- down 3%
2014: $2,210bn
|
Credit risk2 RWA density
41%
2014: 43%
|
||
Leverage ratio
5.0%
2014: 4.8%
|
|
1 From 1 January 2015 the CRD IV transitional CET1 and end point CET1 capital ratios became aligned for HSBC Holdings plc due to the recognition of unrealised gains on investment property and AFS securities.
|
|
2 'Credit risk', here and in all tables and metrics where the term is used, excludes counterparty credit risk.
|
|
|
RWAs
|
Capital required1
|
|||||||
2015
|
2014
|
2015
|
2014
|
|||||
$bn
|
$bn
|
$bn
|
$bn
|
|||||
Credit risk
|
875.9
|
955.3
|
70.1
|
76.4
|
||||
- standardised approach
|
332.7
|
356.9
|
26.6
|
28.6
|
||||
- IRB foundation approach
|
27.4
|
16.8
|
2.2
|
1.3
|
||||
- IRB advanced approach
|
515.8
|
581.6
|
41.3
|
46.5
|
||||
Counterparty credit risk
|
69.2
|
90.7
|
5.5
|
7.3
|
||||
- standardised approach
|
19.1
|
25.2
|
1.5
|
2.0
|
||||
- advanced approach
|
50.1
|
65.5
|
4.0
|
5.3
|
||||
Market risk
|
42.5
|
56.0
|
3.4
|
4.5
|
||||
Operational risk
|
115.4
|
117.8
|
9.2
|
9.4
|
||||
At 31 December
|
1,103.0
|
1,219.8
|
88.2
|
97.6
|
||||
Of which:
|
||||||||
Run-off portfolios
|
69.3
|
99.2
|
5.6
|
7.9
|
||||
- legacy credit in GB&M
|
29.8
|
44.1
|
2.4
|
3.5
|
||||
- US CML and Other2
|
39.5
|
55.1
|
3.2
|
4.4
|
|
1 'Capital required', here and in all tables where the term is used, represents the Pillar I capital charge at 8% of RWAs.
|
|
2 'Other' includes treasury services related to the US CML business and operations in run-off.
|
Europe
|
Asia
|
MENA
|
North
America
|
Latin
America
|
Total
RWAs
|
Capital
required
|
||||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
||||||||
Retail Banking and Wealth Management1
|
38.9
|
63.7
|
7.7
|
57.3
|
21.9
|
189.5
|
15.2
|
|||||||
Commercial Banking1
|
114.3
|
201.1
|
26.1
|
55.3
|
24.2
|
421.0
|
33.7
|
|||||||
Global Banking and Markets2
|
170.4
|
167.3
|
24.7
|
70.6
|
27.1
|
440.6
|
35.2
|
|||||||
Global Private Banking
|
10.7
|
3.9
|
0.3
|
4.2
|
0.2
|
19.3
|
1.5
|
|||||||
Other3
|
3.1
|
23.7
|
1.6
|
4.2
|
-
|
32.6
|
2.6
|
|||||||
At 31 December 2015
|
337.4
|
459.7
|
60.4
|
191.6
|
73.4
|
1,103.0
|
88.2
|
|||||||
Retail Banking and Wealth Management1
|
42.4
|
59.1
|
7.7
|
73.5
|
24.5
|
207.2
|
16.6
|
|||||||
Commercial Banking1
|
106.3
|
208.6
|
26.0
|
58.2
|
31.2
|
430.3
|
34.4
|
|||||||
Global Banking and Markets2
|
209.8
|
193.0
|
27.8
|
81.2
|
32.9
|
516.1
|
41.3
|
|||||||
Global Private Banking
|
11.9
|
3.5
|
0.3
|
4.9
|
0.2
|
20.8
|
1.7
|
|||||||
Other3
|
5.0
|
35.6
|
1.2
|
3.6
|
-
|
45.4
|
3.6
|
|||||||
At 31 December 2014
|
375.4
|
499.8
|
63.0
|
221.4
|
88.8
|
1,219.8
|
97.6
|
|
|
|
1 In the first half of 2015, a portfolio of customers was transferred from CMB to RBWM in Latin America in order to better align the combined banking needs of the customers with our established global businesses. Comparative data have been re-presented accordingly.
|
|
2 RWAs are non-additive across regions due to market risk diversification effects within the Group.
|
|
3 Includes HSBC's holding company and financing operations, unallocated investment activities, centrally held investment companies and certain property transactions.
|
Europe
|
Asia
|
MENA
|
North
America
|
Latin
America
|
Total
RWAs
|
Capital
required
|
||||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
||||||||
Credit risk
|
239.4
|
373.6
|
51.4
|
156.4
|
55.1
|
875.9
|
70.1
|
|||||||
Counterparty credit risk
|
32.1
|
17.1
|
1.8
|
14.6
|
3.6
|
69.2
|
5.5
|
|||||||
Market risk1
|
31.0
|
21.9
|
1.0
|
6.5
|
1.6
|
42.5
|
3.4
|
|||||||
Operational risk
|
34.9
|
47.1
|
6.2
|
14.1
|
13.1
|
115.4
|
9.2
|
|||||||
At 31 December 2015
|
337.4
|
459.7
|
60.4
|
191.6
|
73.4
|
1,103.0
|
88.2
|
|||||||
Credit risk
|
263.2
|
399.1
|
54.6
|
171.6
|
66.8
|
955.3
|
76.4
|
|||||||
Counterparty credit risk
|
40.6
|
21.9
|
1.2
|
23.0
|
4.0
|
90.7
|
7.3
|
|||||||
Market risk1
|
36.1
|
33.0
|
1.0
|
11.6
|
2.9
|
56.0
|
4.5
|
|||||||
Operational risk
|
35.5
|
45.8
|
6.2
|
15.2
|
15.1
|
117.8
|
9.4
|
|||||||
At 31 December 2014
|
375.4
|
499.8
|
63.0
|
221.4
|
88.8
|
1,219.8
|
97.6
|
|
1 RWAs are non-additive across geographical regions due to market risk diversification effects within the Group.
|
|
Click on the attached PDF to view the chart
|
|
http://www.rns-pdf.londonstockexchange.com/rns/6692P_-2016-2-21.pdf
|
All RWAs by risk type
|
Credit risk RWAs by Basel approach
|
|
|
||
RWAs by region
|
RWAs by global business
|
|
|
|
The principal changes in our Pillar 3 Disclosures 2015, compared with 2014, are:
· enhanced capital and leverage disclosures:
- additional disclosure on the impact of the CCyB
- disclosures on the leverage ratio now follow the EBA disclosure templates
· more granular risk disclosures:
- the tables on wholesale IRB exposure by obligor grade and retail IRB exposure by PD band have been expanded to show average exposure value and undrawn commitments by grade/band
- new section and tables on past due but not impaired, impaired exposures and CRA
- new tables showing PD, LGD, RWA and exposure by country
· other items:
- new appendix summarising disclosures withheld due to their immateriality, confidentiality or proprietary nature
|
Accounting
balance
sheet
|
Deconsolidation
of insurance/
other entities
|
Consolidation
of banking
associates
|
Regulatory
balance
sheet
|
|||||
Ref
|
$m
|
$m
|
$m
|
$m
|
||||
Assets
|
||||||||
Cash and balances at central banks
|
98,934
|
(2)
|
28,784
|
127,716
|
||||
Items in the course of collection from other banks
|
5,768
|
-
|
22
|
5,790
|
||||
Hong Kong Government certificates of indebtedness
|
28,410
|
-
|
-
|
28,410
|
||||
Trading assets
|
224,837
|
340
|
4,390
|
229,567
|
||||
Financial assets designated at fair value
|
23,852
|
(23,521)
|
2,034
|
2,365
|
||||
Derivatives
|
288,476
|
(146)
|
495
|
288,825
|
||||
Loans and advances to banks
|
90,401
|
(3,008)
|
16,413
|
103,806
|
||||
Loans and advances to customers
|
924,454
|
(7,427)
|
120,016
|
1,037,043
|
||||
of which:
|
||||||||
- impairment allowances on IRB portfolios
|
i
|
(6,291)
|
-
|
-
|
(6,291)
|
|||
- impairment allowances on standardised portfolios
|
(3,263)
|
-
|
(2,780)
|
(6,043)
|
||||
Reverse repurchase agreements - non-trading
|
146,255
|
711
|
5,935
|
152,901
|
||||
Financial investments
|
428,955
|
(51,684)
|
42,732
|
420,003
|
||||
Assets held for sale
|
43,900
|
(4,107)
|
-
|
39,793
|
||||
of which:
|
||||||||
- goodwill and intangible assets
|
h
|
1,680
|
(219)
|
-
|
1,461
|
|||
- impairment allowances
|
(1,454)
|
-
|
-
|
(1,454)
|
||||
of which:
|
||||||||
- IRB portfolios
|
i
|
(7)
|
-
|
-
|
(7)
|
|||
- standardised portfolios
|
(1,447)
|
-
|
-
|
(1,447)
|
||||
Capital invested in insurance and other entities
|
-
|
2,371
|
-
|
2,371
|
||||
Current tax assets
|
1,221
|
(15)
|
-
|
1,206
|
||||
Prepayments, accrued income and other assets
|
54,398
|
(2,539)
|
9,692
|
61,551
|
||||
of which:
|
||||||||
- retirement benefit assets
|
g
|
5,272
|
-
|
-
|
5,272
|
|||
Interests in associates and joint ventures
|
19,139
|
-
|
(18,571)
|
568
|
||||
of which:
|
||||||||
- positive goodwill on acquisition
|
h
|
593
|
-
|
(579)
|
14
|
|||
Goodwill and intangible assets
|
h
|
24,605
|
(6,068)
|
623
|
19,160
|
|||
Deferred tax assets
|
n
|
6,051
|
195
|
518
|
6,764
|
|||
Total assets at 31 December 2015
|
2,409,656
|
(94,900)
|
213,083
|
2,527,839
|
Accounting
balance
sheet
|
Deconsolidation
of insurance/
other entities
|
Consolidation
of banking
associates
|
Regulatory
balance
sheet
|
|||||
Ref
|
$m
|
$m
|
$m
|
$m
|
||||
Liabilities and equity
|
||||||||
Hong Kong currency notes in circulation
|
28,410
|
-
|
-
|
28,410
|
||||
Deposits by banks
|
54,371
|
(97)
|
50,005
|
104,279
|
||||
Customer accounts
|
1,289,586
|
(119)
|
147,522
|
1,436,989
|
||||
Repurchase agreements - non-trading
|
80,400
|
-
|
-
|
80,400
|
||||
Items in course of transmission to other banks
|
5,638
|
-
|
-
|
5,638
|
||||
Trading liabilities
|
141,614
|
(66)
|
59
|
141,607
|
||||
Financial liabilities designated at fair value
|
66,408
|
(6,046)
|
-
|
60,362
|
||||
of which:
|
||||||||
- term subordinated debt included in tier 2 capital
|
m
|
21,168
|
-
|
-
|
21,168
|
|||
- hybrid capital securities included in tier 1 capital
|
j
|
1,342
|
-
|
-
|
1,342
|
|||
Derivatives
|
281,071
|
87
|
508
|
281,666
|
||||
Debt securities in issue
|
88,949
|
(7,885)
|
5,065
|
86,129
|
||||
Liabilities of disposal groups held for sale
|
36,840
|
(3,690)
|
-
|
33,150
|
||||
Current tax liabilities
|
783
|
(84)
|
409
|
1,108
|
||||
Liabilities under insurance contracts
|
69,938
|
(69,938)
|
-
|
-
|
||||
Accruals, deferred income and other liabilities
|
38,116
|
2,326
|
6,669
|
47,111
|
||||
of which:
|
||||||||
- retirement benefit liabilities
|
2,809
|
(2)
|
61
|
2,868
|
||||
Provisions
|
5,552
|
(25)
|
-
|
5,527
|
||||
of which:
|
||||||||
- contingent liabilities and contractual commitments
|
240
|
-
|
-
|
240
|
||||
of which:
|
||||||||
- credit-related provisions on IRB portfolios
|
i
|
201
|
-
|
-
|
201
|
|||
- credit-related provisions on standardised portfolios
|
39
|
-
|
-
|
39
|
||||
Deferred tax liabilities
|
1,760
|
(868)
|
5
|
897
|
||||
Subordinated liabilities
|
22,702
|
-
|
2,841
|
25,543
|
||||
of which:
|
||||||||
- hybrid capital securities included in tier 1 capital
|
j
|
1,929
|
-
|
-
|
1,929
|
|||
- perpetual subordinated debt included in tier 2 capital
|
l
|
2,368
|
-
|
-
|
2,368
|
|||
- term subordinated debt included in tier 2 capital
|
m
|
18,405
|
-
|
-
|
18,405
|
|||
Total shareholders' equity
|
a
|
188,460
|
(7,562)
|
-
|
180,898
|
|||
of which:
|
||||||||
- other equity instruments included in tier 1 capital
|
c, j
|
15,112
|
-
|
-
|
15,112
|
|||
- preference share premium included in tier 1 capital
|
b
|
1,405
|
-
|
-
|
1,405
|
|||
Non-controlling interests
|
d
|
9,058
|
(933)
|
-
|
8,125
|
|||
of which:
|
||||||||
- non-cumulative preference shares issued by subsidiaries
included in tier 1 capital
|
e
|
2,077
|
-
|
-
|
2,077
|
|||
- non-controlling interests included in tier 2 capital, cumulative preferred stock
|
f
|
-
|
-
|
-
|
-
|
|||
- non-controlling interests attributable to holders of
ordinary shares in subsidiaries included in tier 2 capital
|
f, m
|
-
|
-
|
-
|
-
|
|||
Total liabilities and equity at 31 December 2015
|
2,409,656
|
(94,900)
|
213,083
|
2,527,839
|
Accounting
balance
sheet
|
Deconsolidation
of insurance/
other entities
|
Consolidation
of banking
associates
|
Regulatory
balance
sheet
|
|||||
Ref
|
$m
|
$m
|
$m
|
$m
|
||||
Assets
|
||||||||
Cash and balances at central banks
|
129,957
|
-
|
30,731
|
160,688
|
||||
Items in the course of collection from other banks
|
4,927
|
-
|
80
|
5,007
|
||||
Hong Kong Government certificates of indebtedness
|
27,674
|
-
|
-
|
27,674
|
||||
Trading assets
|
304,193
|
(720)
|
2,357
|
305,830
|
||||
Financial assets designated at fair value
|
29,037
|
(28,791)
|
3,312
|
3,558
|
||||
Derivatives
|
345,008
|
(94)
|
353
|
345,267
|
||||
Loans and advances to banks
|
112,149
|
(2,727)
|
7,992
|
117,414
|
||||
Loans and advances to customers
|
974,660
|
(10,809)
|
116,484
|
1,080,335
|
||||
of which:
|
||||||||
- impairment allowances on IRB portfolios
|
i
|
(6,942)
|
-
|
-
|
(6,942)
|
|||
- impairment allowances on standardised portfolios
|
(5,395)
|
-
|
(2,744)
|
(8,139)
|
||||
Reverse repurchase agreements - non-trading
|
161,713
|
(30)
|
7,510
|
169,193
|
||||
Financial investments
|
415,467
|
(50,420)
|
33,123
|
398,170
|
||||
Capital invested in insurance and other entities
|
-
|
2,542
|
-
|
2,542
|
||||
Current tax assets
|
1,309
|
(16)
|
-
|
1,293
|
||||
Prepayments, accrued income and other assets
|
75,176
|
(5,295)
|
8,501
|
78,382
|
||||
of which:
|
||||||||
- goodwill and intangible assets of disposal groups held for sale
|
h
|
8
|
-
|
-
|
8
|
|||
- retirement benefit assets
|
g
|
5,028
|
-
|
-
|
5,028
|
|||
- impairment allowances on assets held for sale
|
(16)
|
-
|
-
|
(16)
|
||||
of which:
|
||||||||
- IRB portfolios
|
i
|
(16)
|
-
|
-
|
(16)
|
|||
- standardised portfolios
|
-
|
-
|
-
|
-
|
||||
Interests in associates and joint ventures
|
18,181
|
-
|
(17,479)
|
702
|
||||
of which:
|
||||||||
- positive goodwill on acquisition
|
h
|
621
|
-
|
(606)
|
15
|
|||
Goodwill and intangible assets
|
h
|
27,577
|
(5,593)
|
571
|
22,555
|
|||
Deferred tax assets
|
n
|
7,111
|
163
|
474
|
7,748
|
|||
Total assets at 31 December 2014
|
2,634,139
|
(101,790)
|
194,009
|
2,726,358
|
Accounting
balance
sheet
|
Deconsolidation
of insurance/
other entities
|
Consolidation
of banking
associates
|
Regulatory
balance
sheet
|
|||||
Ref
|
$m
|
$m
|
$m
|
$m
|
||||
Liabilities and equity
|
||||||||
Hong Kong currency notes in circulation
|
27,674
|
-
|
-
|
27,674
|
||||
Deposits by banks
|
77,426
|
(21)
|
40,530
|
117,935
|
||||
Customer accounts
|
1,350,642
|
(535)
|
141,858
|
1,491,965
|
||||
Repurchase agreements - non-trading
|
107,432
|
-
|
-
|
107,432
|
||||
Items in course of transmission to other banks
|
5,990
|
(3)
|
-
|
5,987
|
||||
Trading liabilities
|
190,572
|
(42)
|
50
|
190,580
|
||||
Financial liabilities designated at fair value
|
76,153
|
(6,317)
|
-
|
69,836
|
||||
of which:
|
||||||||
- term subordinated debt included in tier 2 capital
|
m
|
21,822
|
-
|
-
|
21,822
|
|||
- hybrid capital securities included in tier 1 capital
|
j
|
1,495
|
-
|
-
|
1,495
|
|||
Derivatives
|
340,669
|
37
|
331
|
341,037
|
||||
Debt securities in issue
|
95,947
|
(7,797)
|
3,720
|
91,870
|
||||
Current tax liabilities
|
1,213
|
(138)
|
317
|
1,392
|
||||
Liabilities under insurance contracts
|
73,861
|
(73,861)
|
-
|
-
|
||||
Accruals, deferred income and other liabilities
|
53,396
|
(3,659)
|
5,145
|
54,882
|
||||
of which:
|
||||||||
- retirement benefit liabilities
|
3,208
|
(2)
|
56
|
3,262
|
||||
Provisions
|
4,998
|
(63)
|
-
|
4,935
|
||||
of which:
|
||||||||
- contingent liabilities and contractual commitments
|
234
|
-
|
-
|
234
|
||||
of which:
|
||||||||
- credit-related provisions on IRB portfolios
|
i
|
132
|
-
|
-
|
132
|
|||
- credit-related provisions on standardised portfolios
|
102
|
-
|
-
|
102
|
||||
Deferred tax liabilities
|
1,524
|
(1,009)
|
2
|
517
|
||||
Subordinated liabilities
|
26,664
|
-
|
2,056
|
28,720
|
||||
of which:
|
||||||||
- hybrid capital securities included in tier 1 capital
|
j
|
2,761
|
-
|
-
|
2,761
|
|||
- perpetual subordinated debt included in tier 2 capital
|
l
|
2,773
|
-
|
-
|
2,773
|
|||
- term subordinated debt included in tier 2 capital
|
m
|
21,130
|
-
|
-
|
21,130
|
|||
Total shareholders' equity
|
a
|
190,447
|
(7,531)
|
-
|
182,916
|
|||
of which:
|
||||||||
- other equity instruments included in tier 1 capital
|
c, j
|
11,532
|
-
|
-
|
11,532
|
|||
- preference share premium included in tier 1 capital
|
b
|
1,405
|
-
|
-
|
1,405
|
|||
Non-controlling interests
|
d
|
9,531
|
(851)
|
-
|
8,680
|
|||
of which:
|
||||||||
- non-cumulative preference shares issued by subsidiaries included in tier 1 capital
|
e
|
2,127
|
-
|
-
|
2,127
|
|||
- non-controlling interests included in tier 2 capital, cumulative preferred stock
|
f
|
300
|
-
|
-
|
300
|
|||
- non-controlling interests attributable to holders of
ordinary shares in subsidiaries included in tier 2 capital
|
f, m
|
173
|
-
|
-
|
173
|
|||
|
||||||||
Total liabilities and equity at 31 December 2014
|
2,634,139
|
(101,790)
|
194,009
|
2,726,358
|
|
The references (a) - (n) identify balance sheet components which are used in the calculation of regulatory capital on page 20.
|
At 31 December 2015
|
At 31 December 2014
|
||||||||
Principal activities
|
Total assets
|
Total
equity
|
Total
assets
|
Total
equity
|
|||||
$m
|
$m
|
$m
|
$m
|
||||||
Principal associates
|
|||||||||
Bank of Communications Co., Limited1
|
Banking services
|
1,110,088
|
80,657
|
1,001,995
|
74,094
|
||||
The Saudi British Bank
|
Banking services
|
50,189
|
7,356
|
50,161
|
6,807
|
||||
Principal insurance entities excluded from the
regulatory consolidation
|
|||||||||
HSBC Life (UK) Ltd
|
Life insurance manufacturing
|
1,941
|
390
|
9,113
|
520
|
||||
HSBC Assurances Vie (France)
|
Life insurance manufacturing
|
23,713
|
663
|
26,260
|
714
|
||||
HSBC Life (International) Ltd
|
Life insurance manufacturing
|
34,808
|
2,805
|
32,578
|
2,778
|
||||
Hang Seng Insurance Company Ltd
|
Life insurance manufacturing
|
14,455
|
1,154
|
13,353
|
1,323
|
||||
HSBC Insurance (Singapore) Pte Ltd
|
Life insurance manufacturing
|
3,102
|
315
|
2,843
|
379
|
||||
HSBC Life Insurance Company Ltd
|
Life insurance manufacturing
|
764
|
109
|
560
|
87
|
||||
HSBC Amanah Takaful (Malaysia) SB
|
Life insurance manufacturing
|
302
|
27
|
349
|
31
|
||||
HSBC Seguros (Brasil) S.A.
|
Life insurance manufacturing
|
484
|
283
|
619
|
357
|
||||
HSBC Vida e Previdência (Brasil) S.A.
|
Life insurance manufacturing
|
3,418
|
155
|
5,044
|
119
|
||||
HSBC Seguros de Vida (Argentina) S.A.
|
Life insurance manufacturing
|
203
|
42
|
225
|
55
|
||||
HSBC Seguros de Retiro (Argentina) S.A.
|
Life insurance manufacturing
|
563
|
102
|
633
|
74
|
||||
HSBC Seguros S.A. (Mexico)
|
Life insurance manufacturing
|
870
|
182
|
1,013
|
199
|
||||
Principal SPEs excluded from the regulatory consolidation2
|
|||||||||
Regency Assets Ltd
|
Securitisation
|
15,183
|
-
|
10,984
|
-
|
||||
Mazarin Funding Ltd
|
Securitisation
|
1,879
|
(9)
|
3,913
|
(26)
|
||||
Barion Funding Ltd
|
Securitisation
|
1,132
|
68
|
1,970
|
90
|
||||
Malachite Funding Ltd
|
Securitisation
|
442
|
26
|
1,403
|
63
|
||||
|
1 Total assets and total equity at 30 September 2015.
|
|
2 These SPEs hold no or de minimis share capital. The negative equity represents net unrealised losses on unimpaired assets on their balance sheets and negative retained earnings.
|
Credit risk and CCR exposures
Various assets on the regulatory balance sheet, such as intangible goodwill and assets, are excluded from the calculation of the credit risk exposure value as they are deducted from capital. The regulatory balances are adjusted for the effect of the differences in the basis for regulatory and accounting netting, and in the treatment of financial collateral.
Credit risk exposures only When assessing credit risk exposures within the regulatory balance sheet, the Basel Committee's approach used to report the asset in question determines the calculation method for EAD. Using the STD approach, the regulatory exposure value is based on the regulatory balance sheet amount, applying a number of further regulatory adjustments. Using IRB approaches, the regulatory EAD is either determined using supervisory (foundation) or internally modelled (advanced) methods.
EAD takes account of off-balance sheet items, such as the undrawn portion of committed facilities, various trade finance commitments and guarantees, by applying CCFs to these items.
Assets on the regulatory balance sheet, as shown in table 4, are net of impairments. EAD, however, is only reduced for impairments under the standardised approach. Impairments under the IRB approach are not used to reduce the EAD amount.
|
CCR exposures only
For regulatory purposes, trading book items, derivatives and securities financing items in the banking book are treated under the rules for CCR. CCR exposures express the risk that the counterparty to a transaction may default before completing the satisfactory settlement of the transaction. See table 48 for a comparison of derivative accounting balances and CCR exposure for derivatives.
HSBC uses the mark-to-market method and the IMM approach to calculate CCR EAD. Under the mark-to-market method EAD is based on the balance sheet fair value of the instrument plus an add-on for PFE. Under the IMM approach, modelled exposure value replaces the fair value on the balance sheet.
|
Carrying value of items:
|
||||||||||||
Regulatory
balance
|
Subject to
credit risk
|
Subject
to CCR
|
Subject to
securitisation
|
Subject
to the
market risk
|
Subject to
deduction from capital or not subject
to regulatory
capital
|
|||||||
sheet1
|
framework
|
framework2
|
framework3
|
framework
|
requirements
|
|||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
|||||||
Assets
|
||||||||||||
Cash and balances at central banks
|
127.7
|
127.7
|
-
|
-
|
-
|
-
|
||||||
Items in the course of collection from other banks
|
5.8
|
5.8
|
-
|
-
|
-
|
-
|
||||||
Hong Kong Government certificates of indebtedness
|
28.4
|
28.4
|
-
|
-
|
-
|
-
|
||||||
Trading assets
|
229.5
|
4.4
|
17.4
|
-
|
225.1
|
-
|
||||||
Financial assets designated at fair value
|
2.4
|
2.4
|
-
|
-
|
-
|
-
|
||||||
Derivatives
|
288.8
|
0.3
|
287.5
|
0.9
|
288.5
|
-
|
||||||
Loans and advances to banks
|
103.8
|
103.8
|
-
|
-
|
-
|
-
|
||||||
Loans and advances to customers
|
1,037.0
|
1,027.5
|
-
|
9.5
|
-
|
-
|
||||||
Reverse repurchase agreements - non-trading
|
152.9
|
5.9
|
147.0
|
-
|
-
|
|||||||
Financial investments
|
420.0
|
408.7
|
-
|
11.3
|
-
|
-
|
||||||
Assets held for sale
|
39.8
|
32.8
|
5.3
|
-
|
-
|
1.7
|
||||||
Capital invested in insurance and other entities
|
2.4
|
2.4
|
-
|
-
|
-
|
-
|
||||||
Current tax assets
|
1.2
|
1.2
|
-
|
-
|
-
|
-
|
||||||
Prepayments, accrued income and other assets
|
61.5
|
44.9
|
-
|
-
|
11.5
|
5.1
|
||||||
Interests in associates and joint ventures
|
0.6
|
-
|
-
|
-
|
-
|
0.6
|
||||||
Goodwill and intangible assets
|
19.2
|
-
|
-
|
-
|
-
|
19.2
|
||||||
Deferred tax assets
|
6.8
|
7.8
|
-
|
-
|
-
|
(1.0)
|
||||||
Total assets at 31 December 2015
|
2,527.8
|
1,804.0
|
457.2
|
21.7
|
525.1
|
25.6
|
||||||
Cash and balances at central banks
|
160.7
|
160.7
|
-
|
-
|
-
|
-
|
||||||
Items in the course of collection from other banks
|
5.0
|
5.0
|
-
|
-
|
-
|
-
|
||||||
Hong Kong Government certificates of indebtedness
|
27.7
|
27.7
|
-
|
-
|
-
|
-
|
||||||
Trading assets
|
305.8
|
-
|
23.1
|
-
|
305.8
|
1.1
|
||||||
Financial assets designated at fair value
|
3.6
|
3.6
|
-
|
-
|
-
|
-
|
||||||
Derivatives
|
345.3
|
-
|
344.6
|
0.7
|
345.3
|
-
|
||||||
Loans and advances to banks
|
117.4
|
115.3
|
-
|
2.1
|
-
|
-
|
||||||
Loans and advances to customers
|
1,080.3
|
1,078.1
|
-
|
2.2
|
-
|
-
|
||||||
Reverse repurchase agreements - non-trading
|
169.2
|
7.5
|
161.7
|
-
|
-
|
-
|
||||||
Financial investments
|
398.2
|
385.8
|
-
|
12.4
|
-
|
-
|
||||||
Capital invested in insurance and other entities
|
2.5
|
2.5
|
-
|
-
|
-
|
-
|
||||||
Current tax assets
|
1.3
|
1.3
|
-
|
-
|
-
|
-
|
||||||
Prepayments, accrued income and other assets
|
78.4
|
57.6
|
-
|
-
|
15.7
|
5.0
|
||||||
Interests in associates and joint ventures
|
0.7
|
0.7
|
-
|
-
|
-
|
-
|
||||||
Goodwill and intangible assets
|
22.6
|
-
|
-
|
-
|
-
|
22.6
|
||||||
Deferred tax assets
|
7.7
|
6.7
|
-
|
-
|
-
|
1.0
|
||||||
Total assets at 31 December 2014
|
2,726.4
|
1,852.5
|
529.4
|
17.4
|
666.8
|
29.7
|
|
1 The amounts shown in the column 'Regulatory balance sheet' do not equal the sum of the amounts shown in the remaining columns of this table for line items 'Derivatives' and 'Trading assets', as some of the assets included
in these items are subject to regulatory capital charges for both CCR and market risk. |
|
2 The amounts shown in the column 'Subject to CCR framework' include both banking book and trading book.
|
|
3 The amounts shown in the column 'Subject to securitisation framework' only include banking book. Trading book securitisation positions are included in the market risk column.
|
Items subject to:
|
||||||
Credit risk
|
CCR
|
Securitisation
framework
|
||||
$bn
|
$bn
|
$bn
|
||||
Asset carrying value amount under scope of regulatory consolidation
|
1,804.0
|
457.2
|
21.7
|
|||
- differences due to reversal of IFRSs netting
|
31.7
|
-
|
-
|
|||
- differences due to financial collateral on standardised approach
|
(13.8)
|
-
|
-
|
|||
- differences due to consideration of provisions on IRB approach
|
7.2
|
-
|
0.6
|
|||
- differences due to modelling and standardised CCFs for credit risk and other differences1
|
275.8
|
-
|
19.3
|
|||
- differences due to credit risk mitigation and potential exposures for counterparty risk
|
-
|
(285.5)
|
-
|
|||
- differences due to free deliveries and sundry balances
|
-
|
6.9
|
-
|
|||
Exposure values considered for regulatory purposes at 31 December 2015
|
2,104.9
|
178.6
|
41.6
|
|||
Asset carrying value amount under scope of regulatory consolidation
|
1,852.5
|
529.4
|
17.4
|
|||
- differences due to reversal of IFRSs netting
|
37.5
|
-
|
-
|
|||
- differences due to financial collateral on standardised approach
|
(13.9)
|
-
|
-
|
|||
- differences due to consideration of provisions on IRB approach
|
7.3
|
-
|
-
|
|||
- differences due to modelling and standardised CCFs for credit risk and other differences1
|
289.6
|
-
|
21.4
|
|||
- differences due to credit risk mitigation and potential exposures for counterparty risk
|
-
|
(336.8)
|
-
|
|||
- differences due to free deliveries and sundry balances
|
-
|
8.5
|
-
|
|||
|
||||||
Exposure values considered for regulatory purposes at 31 December 2014
|
2,173.0
|
201.1
|
38.8
|
|
1 This includes the undrawn portion of committed facilities, various trade finance commitments and guarantees, by applying CCFs to these items.
|
Risk category
|
Scope of permissible approaches
|
Approach adopted by HSBC
|
||
Credit risk
|
The Basel Committee framework applies three approaches of increasing sophistication to the calculation of Pillar 1 credit risk capital requirements. The most basic level, the standardised approach, requires banks to use external credit ratings to determine the risk weightings applied to rated counterparties. Other counterparties are grouped into broad categories and standardised risk weightings are applied to these categories. The next level, the IRB foundation approach, allows banks to calculate their credit risk capital requirements on the basis of their internal assessment of a counterparty's PD, but subjects their quantified estimates of EAD and LGD to standard supervisory parameters. Finally, the IRB advanced approach allows banks to use their own internal assessment in both determining PD and quantifying EAD and LGD.
|
For consolidated Group reporting, we have adopted the advanced IRB approach for the majority of our business.
Some portfolios remain on the standardised or foundation IRB approaches:
· pending the issuance of local regulations or model approval;
· following supervisory prescription of a non-advanced approach; or
· under exemptions from IRB treatment.
Further information on our IRB roll-out plan may be found on page 46.
|
||
Counterparty credit risk
|
Three approaches to calculating CCR and determining exposure values are defined by the Basel Committee: mark-to-market, standardised and IMM. These exposure values are used to determine capital requirements under one of the credit risk approaches; standardised, IRB foundation and IRB advanced.
|
We use the mark-to-market and IMM approaches for CCR. Details of the IMM permission we have received from the PRA can be found in the Financial Services Register on the PRA website. Our aim is to increase the proportion of positions on IMM over time.
|
||
Equity
|
For banking book, equity exposures can be assessed under standardised or IRB approaches.
|
For Group reporting purposes all equity exposures are treated under the standardised approach.
|
||
Securitisation
|
Basel specifies two methods for calculating credit risk requirements for securitisation positions in the banking book: the standardised approach and the IRB approach, which incorporates the RBM, the IAA and the SFM.
|
For the majority of the securitisation non-trading book positions we use the IRB approach, and within this principally the RBM, with lesser amounts on the IAA and the SFM. We also use the standardised approach for an immaterial amount of non-trading book positions. Securitisation positions in the trading book are treated within market risk, using the PRA's standard rules.
|
||
Market risk
|
Market risk capital requirements can be determined under either the standard rules or the IMA. The latter involves the use of internal VaR models to measure market risks and determine the appropriate capital requirement.
The IRC also applies.
|
The market risk capital requirement is measured using internal market risk models, where approved by the PRA, or under the standard rules. Our internal market risk models comprise VaR, stressed VaR and IRC. Non-proprietary details of the scope of our IMA permission are available in the Financial Services Register on the PRA website. We are in compliance with the requirements set out in Articles 104 and 105 of the Capital Requirements Regulation.
|
||
Operational risk
|
The Basel Committee allows for firms to calculate their operational risk capital requirement under the basic indicator approach, the standardised approach or the advanced measurement approach.
|
We have historically adopted and currently use the standardised approach in determining our operational risk capital requirement.
We are in the process of implementing an operational risk model which we will use for economic capital calculation purposes.
|
At 31 December
|
|||||
Ref1
|
2015
$m
|
2014
$m
|
|||
Common equity tier 1 capital
|
|||||
Shareholders' equity
|
160,664
|
166,617
|
|||
- shareholders' equity per balance sheet2
|
a
|
188,460
|
190,447
|
||
- foreseeable interim dividend3
|
(3,717)
|
(3,362)
|
|||
- preference share premium
|
b
|
(1,405)
|
(1,405)
|
||
- other equity instruments
|
c
|
(15,112)
|
(11,532)
|
||
- deconsolidation of special purpose entities4
|
a
|
(91)
|
(323)
|
||
- deconsolidation of insurance entities
|
a, h
|
(7,471)
|
(7,208)
|
||
Non-controlling interests
|
3,519
|
4,640
|
|||
- non-controlling interests per balance sheet
|
d
|
9,058
|
9,531
|
||
- preference share non-controlling interests
|
e
|
(2,077)
|
(2,127)
|
||
- non-controlling interests transferred to tier 2 capital
|
f
|
-
|
(473)
|
||
- non-controlling interests in deconsolidated subsidiaries
|
d
|
(933)
|
(851)
|
||
- surplus non-controlling interests disallowed in CET1
|
(2,529)
|
(1,440)
|
|||
Regulatory adjustments to the accounting basis
|
(4,556)
|
(3,556)
|
|||
- own credit spread5
|
(159)
|
767
|
|||
- debit valuation adjustment
|
(336)
|
(197)
|
|||
- defined benefit pension fund adjustment
|
g
|
(4,009)
|
(4,069)
|
||
- cash flow hedging reserve
|
(52)
|
(57)
|
|||
Deductions
|
(28,764)
|
(31,748)
|
|||
- goodwill and intangible assets
|
h
|
(20,650)
|
(22,475)
|
||
- deferred tax assets that rely on future profitability (excludes those arising from temporary differences)
|
n
|
(1,204)
|
(1,036)
|
||
- additional valuation adjustment (referred to as PVA)
|
(1,151)
|
(1,341)
|
|||
- investments in own shares through the holding of composite products of which HSBC is a component (exchange traded funds, derivatives and index stock)
|
(839)
|
(1,083)
|
|||
- negative amounts resulting from the calculation of expected loss amounts
|
i
|
(4,920)
|
(5,813)
|
||
-
|
|||||
Common equity tier 1 capital on an end point basis
|
130,863
|
135,953
|
|||
Tier 1 and tier 2 capital on a transitional basis
|
|||||
Common equity tier 1 capital on an end point basis
|
130,863
|
135,953
|
|||
Transitional adjustments
|
(2,753)
|
||||
- unrealised gains arising from revaluation of property
|
(1,375)
|
||||
- unrealised gains in available-for-sale debt and equities
|
(1,378)
|
||||
Common equity tier 1 capital on a transitional basis
|
130,863
|
133,200
|
|||
Additional tier 1 capital on a transitional basis
|
|||||
Other tier 1 capital before deductions
|
22,621
|
19,687
|
|||
- preference share premium
|
b
|
1,015
|
1,160
|
||
- preference share non-controlling interests
|
e
|
1,711
|
1,955
|
||
- allowable non-controlling interest in AT1
|
d
|
1,546
|
884
|
||
- hybrid capital securities
|
j
|
18,349
|
15,688
|
||
Deductions
|
(181)
|
(148)
|
|||
- unconsolidated investments6
|
(121)
|
(148)
|
|||
- holding of own additional tier 1 instruments
|
(60)
|
-
|
|||
Tier 1 capital on a transitional basis
|
153,303
|
152,739
|
|||
Tier 2 capital on a transitional basis
|
|||||
Total qualifying tier 2 capital before deductions
|
36,852
|
38,213
|
|||
- allowable non-controlling interest in tier 2
|
d
|
14
|
99
|
||
- perpetual subordinated debt
|
l
|
1,941
|
2,218
|
||
- term subordinated debt
|
m
|
34,897
|
35,656
|
||
- non-controlling interests in tier 2 capital
|
f
|
-
|
240
|
||
Total deductions other than from tier 1 capital
|
(322)
|
(222)
|
|||
- unconsolidated investments6
|
(282)
|
(222)
|
|||
- holding of own tier 2 instruments
|
(40)
|
-
|
|||
|
|||||
Total regulatory capital on a transitional basis
|
189,833
|
190,730
|
|
1 The references (a) - (n) identify balance sheet components on page 8 which are used in the calculation of regulatory capital.
|
|
2 Includes externally verified profits for the year ended 31 December 2015.
|
|
3 This includes dividends on ordinary shares, quarterly dividends on preference shares and coupons on capital securities, classified as equity.
|
|
4 Mainly comprise unrealised gains/losses in AFS debt securities related to SPEs.
|
|
5 Includes own credit spread on trading liabilities.
|
|
6 Mainly comprise investments in insurance entities.
|
At 31 December
|
||||
2015
$m
|
2014
$m
|
|||
Common equity tier 1 capital on a transitional basis
|
130,863
|
133,200
|
||
Unrealised gains arising from revaluation of property
|
1,375
|
|||
Unrealised gains in available-for-sale debt and equities
|
1,378
|
|||
Common equity tier 1 capital on an end point basis
|
130,863
|
135,953
|
||
Additional tier 1 capital on a transitional basis
|
22,440
|
19,539
|
||
Grandfathered instruments:
Preference share premium
|
(1,015)
|
(1,160)
|
||
Preference share non-controlling interests
|
(1,711)
|
(1,955)
|
||
Hybrid capital securities
|
(9,088)
|
(10,007)
|
||
Transitional provisions:
|
||||
Allowable non-controlling interest in AT1
|
(1,377)
|
(487)
|
||
Unconsolidated investments1
|
121
|
148
|
||
Additional tier 1 capital end point basis
|
9,370
|
6,078
|
||
Tier 1 capital on an end point basis
|
140,233
|
142,031
|
||
Tier 2 capital on a transitional basis
|
36,530
|
37,991
|
||
Grandfathered instruments:
|
||||
Perpetual subordinated debt
|
(1,941)
|
(2,218)
|
||
Term subordinated debt
|
(19,034)
|
(21,513)
|
||
Transitional provisions:
|
||||
Non-controlling interest in tier 2 capital
|
-
|
(240)
|
||
Allowable non-controlling interest in tier 2
|
21
|
396
|
||
Unconsolidated investments1
|
(121)
|
(148)
|
||
Tier 2 capital on an end point basis
|
15,455
|
14,268
|
||
Total regulatory capital on an end point basis
|
155,688
|
156,299
|
|
1 Mainly comprise investments in insurance entities.
|
|
|
At 31 December
|
||||
2015
|
2014
|
|||
$bn
|
$bn
|
|||
Credit risk
|
875.9
|
955.3
|
||
Counterparty credit risk
|
69.2
|
90.7
|
||
Market risk
|
42.5
|
56.0
|
||
Operational risk
|
115.4
|
117.8
|
||
1,103.0
|
1,219.8
|
|
· $38bn as a result of reduced exposures, the partial disposal of our investment in Industrial Bank, a decrease in trading positions subject to the Incremental Risk Charge, client facility reductions and trade compressions;
|
|
· $30bn from refining our calculations, including the further application of the SME supporting factor, a more refined application of CCF, increased usage of 'IRB' models and the move of certain exposures from residual to cash
flow weighted maturity; |
|
· $25bn from process improvements such as better linking of collateral and guarantees to facilities, enhanced risk parameters and the use of more granular data resulting in lower CCFs for off-balance sheet items; and
|
|
· $30bn through the continued reduction in the GB&M legacy credit and US run-off portfolios.
|
|
· CMB, from higher term lending to corporate customers, principally in Europe, North America and Asia, $23bn;
|
|
· our associates, Bank of Communications and Saudi British Bank, $14bn; and
|
|
· GB&M, from higher general lending to corporates which increased RWAs by $10bn, mainly in Europe.
|
Europe
|
Asia
|
MENA
|
North
America
|
Latin
America
|
Total
|
|||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
|||||||
IRB approach
|
192.6
|
195.9
|
19.4
|
122.5
|
12.8
|
543.2
|
||||||
- IRB advanced approach
|
175.1
|
195.9
|
9.5
|
122.5
|
12.8
|
515.8
|
||||||
- IRB foundation approach
|
17.5
|
-
|
9.9
|
-
|
-
|
27.4
|
||||||
Standardised approach
|
46.8
|
177.7
|
32.0
|
33.9
|
42.3
|
332.7
|
||||||
At 31 December 2015
|
239.4
|
373.6
|
51.4
|
156.4
|
55.1
|
875.9
|
||||||
IRB approach
|
216.1
|
213.1
|
15.6
|
142.0
|
11.6
|
598.4
|
||||||
- IRB advanced approach
|
203.3
|
213.1
|
11.6
|
142.0
|
11.6
|
581.6
|
||||||
- IRB foundation approach
|
12.8
|
-
|
4.0
|
-
|
-
|
16.8
|
||||||
Standardised approach
|
47.1
|
186.0
|
39.0
|
29.6
|
55.2
|
356.9
|
||||||
At 31 December 2014
|
263.2
|
399.1
|
54.6
|
171.6
|
66.8
|
955.3
|
Principal
RBWM 1
|
RBWM
(US run-off)
|
Total
RBWM
|
CMB 1
|
GB&M
|
GPB
|
Other
|
Total
|
|||||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
|||||||||
IRB approach
|
59.0
|
33.2
|
92.2
|
218.0
|
214.8
|
8.5
|
9.7
|
543.2
|
||||||||
- IRB advanced approach
|
59.0
|
33.2
|
92.2
|
199.0
|
207.5
|
8.4
|
8.7
|
515.8
|
||||||||
- IRB foundation approach
|
-
|
-
|
-
|
19.0
|
7.3
|
0.1
|
1.0
|
27.4
|
||||||||
Standardised approach
|
57.6
|
3.8
|
61.4
|
172.0
|
69.7
|
7.2
|
22.4
|
332.7
|
||||||||
At 31 December 2015
|
116.6
|
37.0
|
153.6
|
390.0
|
284.5
|
15.7
|
32.1
|
875.9
|
||||||||
IRB approach
|
56.1
|
47.3
|
103.4
|
217.2
|
255.6
|
10.2
|
12.0
|
598.4
|
||||||||
- IRB advanced approach
|
56.1
|
47.3
|
103.4
|
209.2
|
248.1
|
10.0
|
10.9
|
581.6
|
||||||||
- IRB foundation approach
|
-
|
-
|
-
|
8.0
|
7.5
|
0.2
|
1.1
|
16.8
|
||||||||
Standardised approach
|
61.2
|
4.8
|
66.0
|
181.0
|
70.1
|
6.6
|
33.2
|
356.9
|
||||||||
At 31 December 2014
|
117.3
|
52.1
|
169.4
|
398.2
|
325.7
|
16.8
|
45.2
|
955.3
|
|
1 In the first half of 2015, a portfolio of customers was transferred from CMB to RBWM in Latin America in order to better align the combined banking needs of the customers with our established global businesses. Comparative data have been re-presented accordingly.
|
|
· RWAs increased by $23bn across all regions as a result of higher lending. Growth in our associate, BoCom, accounted for $15bn.
|
|
· This was offset by RWA initiatives reducing RWAs by $29bn, mainly comprising portfolios moving to an IRB approach (reducing the standardised approach by $10.2bn and increasing the IRB approach by $7.2bn) and partial disposal of our investment in Industrial Bank reducing RWAs by $12.4bn.
|
Europe
|
Asia
|
MENA
|
North
America
|
Latin
America
|
Total
|
|||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
|||||||
RWAs at 1 January 2015
|
216.1
|
213.1
|
15.6
|
142.0
|
11.6
|
598.4
|
||||||
Foreign exchange movement
|
(10.4)
|
(7.2)
|
(0.6)
|
(4.7)
|
(3.4)
|
(26.3)
|
||||||
Acquisitions and disposals
|
(14.1)
|
-
|
(0.1)
|
(4.9)
|
-
|
(19.1)
|
||||||
Book size
|
11.4
|
2.9
|
(0.5)
|
(2.8)
|
0.4
|
11.4
|
||||||
Book quality
|
(8.0)
|
(6.9)
|
(1.4)
|
0.7
|
3.9
|
(11.7)
|
||||||
Model updates
|
1.2
|
(2.6)
|
4.7
|
0.2
|
0.1
|
3.6
|
||||||
- portfolios moving onto IRB approach
|
(0.1)
|
-
|
4.7
|
0.2
|
0.1
|
4.9
|
||||||
- new/updated models
|
1.3
|
(2.6)
|
-
|
-
|
-
|
(1.3)
|
||||||
Methodology and policy
|
(3.6)
|
(3.4)
|
1.7
|
(8.0)
|
0.2
|
(13.1)
|
||||||
- internal updates
|
(6.2)
|
(5.4)
|
1.6
|
(8.0)
|
0.2
|
(17.8)
|
||||||
- external updates - regulatory
|
2.6
|
2.0
|
0.1
|
-
|
-
|
4.7
|
||||||
|
||||||||||||
Total RWA movement
|
(23.5)
|
(17.2)
|
3.8
|
(19.5)
|
1.2
|
(55.2)
|
||||||
RWAs at 31 December 2015
|
192.6
|
195.9
|
19.4
|
122.5
|
12.8
|
543.2
|
||||||
RWAs at 1 January 2014 on Basel 2.5 basis
|
166.9
|
182.9
|
15.0
|
161.5
|
8.5
|
534.8
|
||||||
Foreign exchange movement
|
(11.6)
|
(4.0)
|
(0.2)
|
(2.4)
|
(1.9)
|
(20.1)
|
||||||
Acquisitions and disposals
|
(3.5)
|
-
|
(0.7)
|
(4.2)
|
(0.1)
|
(8.5)
|
||||||
Book size
|
11.4
|
19.5
|
1.8
|
2.9
|
2.0
|
37.6
|
||||||
Book quality
|
(1.5)
|
-
|
(0.8)
|
(10.3)
|
1.4
|
(11.2)
|
||||||
Model updates
|
19.4
|
0.3
|
-
|
(6.1)
|
-
|
13.6
|
||||||
Methodology and policy
|
35.0
|
14.4
|
0.5
|
0.6
|
1.7
|
52.2
|
||||||
- internal updates
|
(11.7)
|
(5.2)
|
(0.2)
|
(6.4)
|
(0.1)
|
(23.6)
|
||||||
- external updates - regulatory
|
2.2
|
8.5
|
(0.2)
|
0.7
|
0.1
|
11.3
|
||||||
- CRD IV impact
|
37.0
|
5.7
|
0.4
|
4.9
|
0.2
|
48.2
|
||||||
- NCOA moving from STD to IRB
|
7.5
|
5.4
|
0.5
|
1.4
|
1.5
|
16.3
|
||||||
Total RWA movement
|
49.2
|
30.2
|
0.6
|
(19.5)
|
3.1
|
63.6
|
||||||
RWAs at 31 December 2014 on CRD IV basis
|
216.1
|
213.1
|
15.6
|
142.0
|
11.6
|
598.4
|
Principal
RBWM 1
|
RBWM
(US run-off)
|
Total
RBWM
|
CMB1
|
GB&M
|
GPB
|
Other
|
Total
|
|||||||||||||||||||
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
$bn
|
|||||||||||||||||||
RWAs at 1 January 2015
|
56.1
|
47.3
|
103.4
|
217.2
|
255.6
|
10.2
|
12.0
|
598.4
|
||||||||||||||||||
Foreign exchange movement
|
(2.9)
|
-
|
(2.9)
|
(11.7)
|
(11.0)
|
(0.3)
|
(0.4)
|
(26.3)
|
||||||||||||||||||
Acquisitions and disposals
|
-
|
(4.9)
|
(4.9)
|
-
|
(14.2)
|
-
|
-
|
(19.1)
|
||||||||||||||||||
Book size
|
3.7
|
(5.6)
|
(1.9)
|
15.8
|
(0.8)
|
(0.5)
|
(1.2)
|
11.4
|
||||||||||||||||||
Book quality
|
(2.8)
|
(3.7)
|
(6.5)
|
6.0
|
(10.5)
|
(0.1)
|
(0.6)
|
(11.7)
|
||||||||||||||||||
Model updates
|
0.4
|
-
|
0.4
|
5.6
|
(2.3)
|
(0.1)
|
-
|
3.6
|
||||||||||||||||||
- portfolios moving onto IRB approach
|
-
|
-
|
-
|
4.1
|
0.9
|
(0.1)
|
-
|
4.9
|
||||||||||||||||||
- new/updated models
|
0.4
|
-
|
0.4
|
1.5
|
(3.2)
|
-
|
-
|
(1.3)
|
||||||||||||||||||
Methodology and policy
|
4.5
|
0.1
|
4.6
|
(14.9)
|
(2.0)
|
(0.7)
|
(0.1)
|
(13.1)
|
||||||||||||||||||
- internal updates
|
2.5
|
0.1
|
2.6
|
(14.9)
|
(4.7)
|
(0.7)
|
(0.1)
|
(17.8)
|
||||||||||||||||||
- external updates - regulatory
|
2.0
|
-
|
2.0
|
-
|
2.7
|
-
|
-
|
4.7
|
||||||||||||||||||
Total RWA movement
|
2.9
|
(14.1)
|
(11.2)
|
0.8
|
(40.8)
|
1.7
|
(2.3)
|
(55.2)
|
||||||||||||||||||
RWAs at 31 December 2015
|
59.0
|
33.2
|
92.2
|
218.0
|
214.8
|
8.5
|
9.7
|
543.2
|
||||||||||||||||||
RWAs at 1 January 2014 on Basel 2.5 basis
|
58.5
|
72.6
|
131.1
|
189.4
|
198.5
|
10.6
|
5.2
|
534.8
|
||||||||||||||||||
Foreign exchange movement
|
(2.6)
|
-
|
(2.6)
|
(8.7)
|
(8.1)
|
(0.2)
|
(0.5)
|
(20.1)
|
||||||||||||||||||
Acquisitions and disposals
|
-
|
-
|
-
|
-
|
(8.2)
|
-
|
(0.3)
|
(8.5)
|
||||||||||||||||||
Book size
|
1.9
|
(6.9)
|
(5.0)
|
23.1
|
21.1
|
(0.5)
|
(1.1)
|
37.6
|
||||||||||||||||||
Book quality
|
(5.7)
|
(8.6)
|
(14.3)
|
2.8
|
(0.2)
|
(0.3)
|
0.8
|
(11.2)
|
||||||||||||||||||
Model updates
|
0.6
|
(6.2)
|
(5.6)
|
12.2
|
7.0
|
-
|
-
|
13.6
|
||||||||||||||||||
Methodology and policy
|
3.4
|
(3.6)
|
(0.2)
|
(1.6)
|
45.5
|
0.6
|
7.9
|
52.2
|
||||||||||||||||||
- internal updates
|
(3.0)
|
(3.9)
|
(6.9)
|
(5.0)
|
(11.2)
|
(0.5)
|
-
|
(23.6)
|
||||||||||||||||||
- external updates - regulatory
|
1.8
|
-
|
1.8
|
2.5
|
6.3
|
0.5
|
0.2
|
11.3
|
||||||||||||||||||
- CRD IV impact
|
-
|
-
|
-
|
(0.7)
|
48.6
|
0.2
|
0.1
|
48.2
|
||||||||||||||||||
- NCOA moving from STD to IRB
|
4.6
|
0.3
|
4.9
|
1.6
|
1.8
|
0.4
|
7.6
|
16.3
|
||||||||||||||||||
Total RWA movement
|
(2.4)
|
(25.3)
|
(27.7)
|
27.8
|
57.1
|
(0.4)
|
6.8
|
63.6
|
||||||||||||||||||
RWAs at 31 December 2014 on CRD IV basis
|
56.1
|
47.3
|
103.4
|
217.2
|
255.6
|
10.2
|
12.0
|
598.4
|
||||||||||||||||||
|
1 In the first half of 2015, a portfolio of customers was transferred from CMB to RBWM in Latin America in order to better align the combined banking needs of the customers with our established global businesses. Comparative data have been re-presented accordingly.
|
|
· The disposal of US mortgage portfolios reduced RWAs by $4.9bn.
|
|
· The sale of securitisation positions in the GB&M legacy credit portfolio resulted in a RWA decrease of $14bn.
|
|
· The book size grew from higher corporate lending, including term and trade-related lending which increased RWAs by $16bn, mainly in Europe and Asia for CMB.
|
|
· In North America, in RBWM, continued run-off of the US CML retail mortgage portfolios resulted in an RWA reduction of $5.6bn.
|
|
· RWAs reduced by $3.7bn in the US run-off portfolio, primarily due to continued run-off which led to an improvement in the book quality of the residual portfolio;
|
|
· book quality improvements in the Principal RBWM business of $2.8bn mainly related to credit quality improvements in Europe;
|
|
· in CMB, RWAs increased by $6.0bn, primarily as a result of corporate downgrades in Europe;
|
|
· in GB&M, a decrease in RWAs of $10bn was mainly due to the implementation of netting agreements to new corporate counterparties in Europe, the securitisation of corporate loans and rating upgrades of institutions in Asia; and
|
|
· the downgrade of Brazil's rating increased RWAs by $3.7bn across businesses.
|
|
· RWA initiatives were the main driver for the reduction of RWAs driven by changes in 'internal updates'. Further details are provided on page 21.
|
|
· They were offset by the change in RWA calculation on defaulted exposures in RBWM increasing RWAs by $2.0bn, the implementation of a risk-weight floor on mortgages in Hong Kong with an RWA impact of $2.0bn, and the implementation of a 1.06 scaling factor on securitisation positions risk-weighted at 1,250% which increased RWAs by $2.1bn.
|
2015
$bn
|
2014
$bn
|
|||
Advanced approach
|
50.1
|
65.5
|
||
- CCR IRB approach
|
46.8
|
62.0
|
||
- Credit valuation adjustment
|
3.3
|
3.5
|
||
Standardised approach
|
19.1
|
25.2
|
||
- CCR standardised approach
|
4.7
|
4.4
|
||
- Credit valuation adjustment
|
12.2
|
18.0
|
||
- Central counterparty
|
2.2
|
2.8
|
||
|
||||
At 31 December
|
69.2
|
90.7
|
2015
$bn
|
2014
$bn
|
|||
RWAs at 1 January
|
65.5
|
42.2
|
||
Book size
|
(10.2)
|
1.6
|
||
Book quality
|
(0.8)
|
(0.6)
|
||
Model updates
|
-
|
0.1
|
||
Methodology and policy
|
(4.4)
|
22.2
|
||
- internal updates
|
(4.4)
|
(3.8)
|
||
- external updates - regulatory
|
-
|
9.0
|
||
- CRD IV impact
|
-
|
17.0
|
||
Total RWA movement
|
(15.4)
|
23.3
|
||
RWAs at 31 December
|
50.1
|
65.5
|
2015
|
2014
|
|||
$bn
|
$bn
|
|||
Internal model based
|
34.9
|
44.6
|
||
- VaR
|
7.7
|
7.3
|
||
- stressed VaR
|
9.8
|
10.4
|
||
- incremental risk charge
|
11.4
|
20.1
|
||
- other VaR and stressed VaR
|
6.0
|
6.8
|
||
|
||||
Standardised approach
|
7.6
|
11.4
|
||
Year to 31 December
|
42.5
|
56.0
|
2015
|
2014
|
|||
$bn
|
$bn
|
|||
RWAs at 1 January
|
44.6
|
52.2
|
||
Acquisitions and disposals
|
-
|
(2.2)
|
||
Movement in risk levels
|
(5.5)
|
(4.2)
|
||
Methodology and policy
|
(4.2)
|
(1.2)
|
||
- internal updates
|
(4.2)
|
(3.8)
|
||
- external updates - regulatory
|
-
|
2.6
|
||
-
|
||||
Total RWA movement
|
(9.7)
|
(7.6)
|
||
RWAs at 31 December
|
34.9
|
44.6
|
|
· remain sufficient to support our risk profile and outstanding commitments;
|
|
· exceed current regulatory requirements, and that HSBC is well placed to meet those expected in the future;
|
|
· allow the bank to remain adequately capitalised in the event of a severe economic downturn stress scenario; and
|
|
· remain consistent with our strategic and operational goals and our shareholder and investor expectations.
|
Ref1
|
At
31 December
2015
|
||
$bn
|
|||
1
|
Total assets as per published financial statements
|
2,410
|
|
2
|
Adjustment for entities which are consolidated for accounting purposes but are outside the scope of regulatory consolidation
|
112
|
|
3
|
Adjustment for fiduciary assets recognised on the balance sheet pursuant to the applicable accounting framework but excluded from the leverage ratio exposure measure
|
-
|
|
4
|
Adjustments for derivative financial instruments
|
(141)
|
|
5
|
Adjustments for securities financing transactions
|
13
|
|
6
|
Adjustment for off-balance sheet items (i.e. conversion to credit equivalent amounts of off-balance sheet exposures)
|
401
|
|
(Adjustment for intragroup exposures excluded from the leverage ratio exposure measure)
|
-
|
||
(Adjustment for exposures excluded from the leverage ratio exposure measure)
|
-
|
||
7
|
Other adjustments
|
(1)
|
|
8
|
Total leverage ratio exposure
|
2,794
|
Ref1
|
At
31 December
2015
|
||
$bn
|
|||
On-balance sheet exposures (excluding derivatives and SFTs)
|
|||
1
|
On-balance sheet items (excluding derivatives, SFTs and fiduciary assets, but including collateral)
|
2,104
|
|
2
|
(Asset amounts deducted in determining Tier 1 capital)
|
(33)
|
|
3
|
Total on-balance sheet exposures (excluding derivatives, SFTs and fiduciary assets)
|
2,071
|
|
Derivative exposures
|
|||
4
|
Replacement cost associated with all derivatives transactions (i.e. net of eligible cash variation margin)
|
31
|
|
5
|
Add-on amounts for PFE associated with all derivatives transactions (mark-to-market method)
|
125
|
|
EU-5a
|
Exposure determined under Original Exposure Method
|
-
|
|
6
|
Gross-up for derivatives collateral provided where deducted from the balance sheet assets pursuant to the applicable accounting framework
|
4
|
|
7
|
(Deductions of receivables assets for cash variation margin provided in derivatives transactions)
|
(31)
|
|
8
|
(Exempted CCP leg of client-cleared trade exposures)
|
-
|
|
9
|
Adjusted effective notional amount of written credit derivatives
|
20
|
|
10
|
(Adjusted effective notional offsets and add-on deductions for written credit derivatives)
|
-
|
|
11
|
Total derivative exposures
|
149
|
|
Securities financing transaction exposures
|
|||
12
|
Gross SFT assets (with no recognition of netting), after adjusting for sales accounting transactions
|
243
|
|
13
|
(Netted amounts of cash payables and cash receivables of gross SFT assets)
|
(78)
|
|
14
|
Counterparty credit risk exposure for SFT assets
|
8
|
|
EU-14a
|
Derogation for SFTs: Counterparty credit risk exposure
|
-
|
|
15
|
Agent transaction exposures
|
-
|
|
EU-15a
|
(Exempted CCP leg of client-cleared SFT exposure)
|
-
|
|
16
|
Total securities financing transaction exposures
|
173
|
|
Other off-balance sheet exposures
|
|||
17
|
Off-balance sheet exposures at gross notional amount
|
906
|
|
18
|
(Adjustments for conversion to credit equivalent amounts)
|
(505)
|
|
19
|
Total off-balance sheet exposures
|
401
|
|
Exempted exposures
|
|||
EU-19a
|
(Exemption of intragroup exposures (solo basis))
|
-
|
|
EU-19b
|
(Exposures exempted)
|
-
|
|
Capital and total exposures
|
|||
20
|
Tier 1 capital
|
140
|
|
21
|
Total leverage ratio exposures
|
2,794
|
|
Leverage ratios
|
|||
22
|
Leverage ratio
|
5.0%
|
|
Choice on transitional arrangements and amount of derecognised fiduciary items
|
|||
EU-23
|
Choice on transitional arrangements for the definition of the capital measure
|
Fully phased in
|
|
EU-24
|
Amount of derecognised fiduciary items
|
-
|
Ref1
|
At
31 December
2015
|
||
$bn
|
|||
EU-1
|
Total on-balance sheet exposures (excluding derivatives, SFTs, and exempted exposures)
of which:
|
2,104
|
|
EU-2
|
Trading book exposures
|
225
|
|
EU-3
|
Banking book exposures
of which:
|
1,879
|
|
EU-4
|
- covered bonds
|
1
|
|
EU-5
|
- exposures treated as sovereigns
|
521
|
|
EU-6
|
- exposures to regional governments, MDB, international organisations and PSE NOT treated as sovereigns
|
1
|
|
EU-7
|
- institutions
|
129
|
|
EU-8
|
- secured by mortgages of immovable properties
|
292
|
|
EU-9
|
- retail exposures
|
113
|
|
EU-10
|
- corporate
|
677
|
|
EU-11
|
- exposures in default
|
15
|
|
EU-12
|
- other exposures (e.g. equity, securitisations, and other non-credit obligation assets)
|
130
|
|
1 The references identify the lines prescribed in the EBA template. Lines represented in this table are those lines which are applicable and where there is a value.
|
Leverage ratio: disclosure on qualitative items:
· The leverage exposure measure is calculated on a regional and global business basis each month and presented to Group ALCO, which monitors the risk of excessive leverage.
· The increase in the leverage ratio to 5.0% (2014: 4.8%) was mainly as a result of the reduction in the size of the balance sheet.
|
Risk management is embedded through:
· a strong risk culture, with personal accountability for decisions;
· a formal risk governance framework, with clear and well understood risk ownership, standards and policies;
· the alignment of risk and business objectives, with integration of risk appetite into business planning and capital management;
· the alignment of remuneration with our risk framework and risk outcomes; and
· an independent, expert global risk function ('Global Risk').
|
Strong risk governance is supported by:
· a clear policy framework of risk ownership;
· a globally consistent risk appetite framework through which the types and quantum of risk that we are prepared to accept in executing our strategy are articulated and monitored;
· performance scorecards cascaded from the GMB that align business and risk objectives; and
· the accountability of all staff for identifying, assessing and managing risks in accordance with the three lines of defence model.
|
Global Risk:
· forms part of the second line of defence, with responsibility for setting policy and for providing oversight and challenge of the activities conducted by the first line;
· supports our global businesses, regions, countries and global functions in the development and achievement of strategic objectives;
· fosters development of a conservative but constructive Group risk culture;
· works with global businesses, regions and global functions in the setting and monitoring of risk appetite;
· carries out central approvals, controls, risk systems design and the analysis and reporting of management information;
· addresses risk issues in dealings with external stakeholders including regulators and analysts;
· is jointly responsible with Global Finance for the delivery of enterprise-wide stress testing; and
· in addition to 'business as usual' operations, engages with business development activities such as new product approval and post-implementation review, and acquisition due diligence.
|